Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

445 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
p53 polymorphism and risk of cervical cancer.
Helland A, Langerød A, Johnsen H, Olsen AO, Skovlund E, Børresen-Dale AL. Helland A, et al. Nature. 1998 Dec 10;396(6711):530-1; author reply 532. doi: 10.1038/25034. Nature. 1998. PMID: 9859987 No abstract available.
p53 polymorphism and cervical cancer.
Helland A, Børresen-Dale AL. Helland A, et al. Lancet. 1999 Oct 30;354(9189):1561-2. doi: 10.1016/S0140-6736(05)76596-X. Lancet. 1999. PMID: 10551531 No abstract available.
Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load.
Helland A, Karlsen F, Due EU, Holm R, Kristensen G, Børresen-Dale Al. Helland A, et al. Br J Cancer. 1998 Jul;78(1):69-72. doi: 10.1038/bjc.1998.444. Br J Cancer. 1998. PMID: 9662253 Free PMC article.
ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral breast cancer.
Bernstein JL, Bernstein L, Thompson WD, Lynch CF, Malone KE, Teitelbaum SL, Olsen JH, Anton-Culver H, Boice JD, Rosenstein BS, Børresen-Dale AL, Gatti RA, Concannon P, Haile RW; WECARE Study Collaborative Group. Bernstein JL, et al. Br J Cancer. 2003 Oct 20;89(8):1513-6. doi: 10.1038/sj.bjc.6601289. Br J Cancer. 2003. PMID: 14562025 Free PMC article.
Excess of miRNA-378a-5p perturbs mitotic fidelity and correlates with breast cancer tumourigenesis in vivo.
Winsel S, Mäki-Jouppila J, Tambe M, Aure MR, Pruikkonen S, Salmela AL, Halonen T, Leivonen SK, Kallio L, Børresen-Dale AL, Kallio MJ. Winsel S, et al. Br J Cancer. 2014 Nov 25;111(11):2142-51. doi: 10.1038/bjc.2014.524. Epub 2014 Sep 30. Br J Cancer. 2014. PMID: 25268374 Free PMC article.
Identifying microRNAs regulating B7-H3 in breast cancer: the clinical impact of microRNA-29c.
Nygren MK, Tekle C, Ingebrigtsen VA, Mäkelä R, Krohn M, Aure MR, Nunes-Xavier CE, Perälä M, Tramm T, Alsner J, Overgaard J, Nesland JM, Borgen E, Børresen-Dale AL, Fodstad Ø, Sahlberg KK, Leivonen SK. Nygren MK, et al. Br J Cancer. 2014 Apr 15;110(8):2072-80. doi: 10.1038/bjc.2014.113. Epub 2014 Feb 27. Br J Cancer. 2014. PMID: 24577056 Free PMC article.
Potential tumorigenic programs associated with TP53 mutation status reveal role of VEGF pathway.
Joshi H, Bhanot G, Børresen-Dale AL, Kristensen V. Joshi H, et al. Br J Cancer. 2012 Nov 6;107(10):1722-8. doi: 10.1038/bjc.2012.461. Epub 2012 Oct 18. Br J Cancer. 2012. PMID: 23079576 Free PMC article.
Glomeruloid microvascular proliferation is associated with lack of response to chemotherapy in breast cancer.
Akslen LA, Straume O, Geisler S, Sørlie T, Chi JT, Aas T, Børresen-Dale AL, Lønning PE. Akslen LA, et al. Br J Cancer. 2011 Jun 28;105(1):9-12. doi: 10.1038/bjc.2011.203. Epub 2011 Jun 14. Br J Cancer. 2011. PMID: 21673677 Free PMC article.
Risk for contralateral breast cancer among carriers of the CHEK2*1100delC mutation in the WECARE Study.
Mellemkjaer L, Dahl C, Olsen JH, Bertelsen L, Guldberg P, Christensen J, Børresen-Dale AL, Stovall M, Langholz B, Bernstein L, Lynch CF, Malone KE, Haile RW, Andersson M, Thomas DC, Concannon P, Capanu M, Boice JD Jr; WECARE Study Collaborative Group, Bernstein JL. Mellemkjaer L, et al. Br J Cancer. 2008 Feb 26;98(4):728-33. doi: 10.1038/sj.bjc.6604228. Epub 2008 Feb 5. Br J Cancer. 2008. PMID: 18253122 Free PMC article.
TP53 mutations in early-stage ovarian carcinoma, relation to long-term survival.
Wang Y, Helland A, Holm R, Skomedal H, Abeler VM, Danielsen HE, Tropé CG, Børresen-Dale AL, Kristensen GB. Wang Y, et al. Br J Cancer. 2004 Feb 9;90(3):678-85. doi: 10.1038/sj.bjc.6601537. Br J Cancer. 2004. PMID: 14760384 Free PMC article.
445 results
Jump to page